Please assess the completion status of the following clinical trial:

Trial Title: Gut Imaging for Function & Transit in Cystic Fibrosis Study 1

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age 12 - 40 years~* Capacity to consent, or to understand the requirements of the study where parental consent is needed~* PATIENTS: confirmed diagnosis of Cystic Fibrosis, either by sweat test or genetic testing; to reduce heterogeneity, we will only enrol homozygous CF patients with the most common CFTR mutation, p.Phe508del~* CONTROLS: no clinical evidence or suspicion of Cystic Fibrosis~Exclusion Criteria:• Measurement of Forced Expiratory Volume in 1 second (FEV1) of \<40% predicted using Global Lung Initiative criteria, according to clinical records~* Contra-indication to MRI scanning, such as embedded metal, pacemaker~* Unable to stop medications directly prescribed to alter bowel habit, such as laxatives of anti-diarrhoeals, on the study day~* Previous resection of any part of the gastro-intestinal tract apart from appendicectomy or cholecystectomy. Surgical relief of distal ileal obstruction syndrome or neonatal ileus will be permitted unless clinical records show excision of intestine \>20cm in length.~* Intestinal stoma~* Diagnosis of inflammatory bowel disease or coeliac disease confirmed by biopsy~* Gastrointestinal malignancy~* Unable to comply with dietary restrictions required for the study

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- CF (Type: None): people with cystic fibrosis
- Control (Type: None): people without cystic fibrosis

Based on this trial design, predict the completion outcome and termination type (if applicable).